A blog about chemistry, drug development, science, and technology
Pfizer is acquiring Powdermed for their new technology related to vaccines.
RED HERRING | Pfizer Nabs Startup PowderMed:
Pfizer wants the technology they have developed to produce vaccines using DNA-caoted microscopic gold particles that can be placed under the skin without a needle using a pressurized gas. Powdermed is developing vaccines for herpes, chronic hepatitis and genital warts.
This is a good acquisition for Pfizer since they don’t have a presence in vaccines and the hope seems to be that this technology will be far ahead of the old egg-based vaccine or the newer developments with cell-based vaccine production.
Technorati Tags: Pfizer, pharma M&A, pharmaceutical deals, Powdermed
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 1.097 seconds